Breadth of antibody activity elicited by an influenza B hemagglutinin vaccine is influenced by pre-existing immune responses to influenza B viruses
Journal of Virology · 2025
DOI: 10.1128/jvi.00705-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Michael A Carlock und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza B virus, Antibodies, Viral, Hemagglutinin Glycoproteins, Influenza Virus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Georgia Research Alliance, NIH HHS.
Abstract (Originalsprache)
Most people are exposed to influenza A and influenza B viruses (IBV) at an early age through natural infection or vaccination. These previous exposures can shape future immune responses and the ability to either recall memory B cells or generate de novo immune responses. Therefore, it is important to consider pre-existing immunity when testing vaccine candidates. The B/Victoria (B/VIC) and the B/Yamagata (B/YAM) lineages circulated in the human population between 1987 and 2020 until the B/YAM lineage stopped circulating following the coronavirus disease 2019 pandemic. Most people born prior to 2020 have pre-existing immune responses to both lineages of IBV. Therefore, in this report, the impact of vaccine-induced antibodies was explored in mice with pre-existing immune responses to B/YAM or B/VIC viruses alone or in combination. The recalled B cell responses induced by modern wild-type hemagglutinin (HA) vaccines from each IBV lineage were compared to the recalled B cell responses elicited by a broadly reactive antigen, B-COBRA-2 (BC2) HA, which elicits cross-lineage neutralizing antibodies. This report highlights the lineage specificity of immunological imprinting with IBV and demonstrates the antigen-specific activation of antibody-secreting B cells by broadly reactive antigens. IMPORTANCE This report demonstrates how varying immunological backgrounds to influenza B virus influence vaccine-induced responses in mice. It further highlights that a broadly reactive influenza B virus hemagglutinin (HA) antigen stimulates higher levels of IgM-secreting cells compared to wild-type HA antigens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA.
- Florida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, Florida, USA.
- Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA.
- Department of Infection Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
ORCID-Profile: Michael A Carlock, Ted M Ross
Förderung
- NIAID NIH HHS
- Georgia Research Alliance
- NIH HHS
- National Institutes of Health
Zitieren
APA
Carlock, M. A., Pierce, S. R., & Ross, T. M. (2025). Breadth of antibody activity elicited by an influenza B hemagglutinin vaccine is influenced by pre-existing immune responses to influenza B viruses. Journal of Virology. https://doi.org/10.1128/jvi.00705-25
Vancouver
Carlock MA, Pierce SR, Ross TM. Breadth of antibody activity elicited by an influenza B hemagglutinin vaccine is influenced by pre-existing immune responses to influenza B viruses. Journal of Virology. 2025. doi:10.1128/jvi.00705-25
BibTeX
@article{Carlock2025,
author = {Carlock, Michael A and Pierce, Spencer R and Ross, Ted M},
title = {Breadth of antibody activity elicited by an influenza B hemagglutinin vaccine is influenced by pre-existing immune responses to influenza B viruses},
journal = {Journal of Virology},
year = {2025},
doi = {10.1128/jvi.00705-25}
}
EUVIMED